EndoClot Plus is Therapeutic Devices in China that focus on therapeutic solutions business. Founded in 2014. They cover business area such as developer, new therapeutic biomaterial, endoscopy, proprietary endoscopic delivery product, polysaccharide hemostatic System, absorbable Modified Polymer, adhesive polymer, innovative and effective treatment, therapeutic solution, practitioner.
2014
( 12 years old in 2026 )
Therapeutic Solutions
-
Unit 101, Building B8, Bio-Nano Park
218 Xinghu Avenue, Suzhou Industrial Park
Suzhou, Jiangsu
China
Private
developernew therapeutic biomaterialendoscopyproprietary endoscopic delivery productpolysaccharide hemostatic Systemabsorbable Modified Polymeradhesive polymerinnovative and effective treatmenttherapeutic solutionpractitioner
* We use standard office opening hours in near EndoClot Plus's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EndoClot Plus is Therapeutic Devices business from China that founded in 2014 (12 years old in 2026), EndoClot Plus business is focusing on Therapeutic Solutions.
EndoClot Plus headquarter office and corporate office address is located in Unit 101, Building B8, Bio-Nano Park 218 Xinghu Avenue, Suzhou Industrial Park Suzhou, Jiangsu China.
EndoClot Plus was founded in China.
In 2026, EndoClot Plus is currently focus on therapeutic solutions sector.
Above is snippet of Google Trends for "therapeutic solutions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EndoClot Plus, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
